Related Experiment Video
Updated: Aug 20, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Lupus erythematosus with leflunomide: induction or reactivation?
D Gensburger1, M Kawashima, H Marotte
1Department of Immunology, Hôpital Edouard Hérriot, 69437 Lyon Cedex 03, France.
Background:
Leflunomide is a new oral disease modifying antirheumatic drug with a good safety profile.
Case Report:
The first case of lupus erythematosus in a 58 year old white woman after administration of leflunomide for primary Sjögren's syndrome is reported. The relationship between induced lupus and leflunomide was confirmed by the resolution of the skin rash when the drug was stopped and its recurrence when it was reintroduced following a dose-response effect.
Discussion:
Peripheral blood cells from this patient, from 15 patients with rheumatoid arthritis, and from healthy controls were used in a bioassay, which suggested that leflunomide affected the Th1/Th2 balance. Such a side effect might be related, in part, to the anti-tumour necrosis factor alpha activity of leflunomide.
Related Concept Videos
Hypersensitivity Reactions: Immune-Complex Reactions
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Hypersensitivity Reactions: Cytolytic Reactions